Sbi Securities Co., Ltd. Scynexis Inc Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Scynexis Inc stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 237 shares of SCYX stock, worth $267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
237Holding current value
$267% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SCYX
# of Institutions
47Shares Held
13.2MCall Options Held
21.9KPut Options Held
2.6K-
Federated Hermes, Inc. Pittsburgh, PA3.6MShares$4.06 Million0.01% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$2.53 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$1.91 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.45MShares$1.64 Million0.13% of portfolio
-
Amh Equity LTD626KShares$707,4380.79% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $36.9M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...